Based on previously documented effects of radiation on inflammation and vascular activation [1,16] and evidence that IDO-blockade has some effect on tumor therapy [14,15], we tested the hypothesis that the IDO protects glioblastoma from the full effects of chemo-radiation therapy by preventing vascular activation and complement-dependent tumor destruction. Here, IDO1 is linked to glioblastoma.